Merck To License COVID-19 Treatment Molnupiravir To Five Indian Generics Makers

Drug major Merck said it entered into non-exclusive voluntary licensing agreements with five Indian generics manufacturers for COVID-19 treatment molnupiravir amid the surging coronavirus cases in India. Molnupiravir (EIDD-2801/MK-4482) is an investigational oral antiviral agent currently being studied in a Phase 3 trial for the treatment of non-hospitalized patients with confirmed COVID-19. Merck is developing […]